Charles River Laboratories shows strong revenue, earnings gains in Q1

By The Science Advisory Board staff writers

May 4, 2021 -- Sales gains across all three of its business segments helped drive Charles River Laboratories to a 16.6% increase in revenue in its 2021 first quarter.

Charles River had first-quarter revenue of $824.6 million, up from $707.1 million reported in the first quarter of 2020. The company's research models and services segment produced a 21.2% increase in revenue, while the discovery and safety assessment segment climbed 14.2% and the manufacturing and support segment generated a 19.7% increase in revenues. Overall, the contract research organization had first-quarter net income of $61.5 million, compared with $50.8 million a year ago.

Based on the strong first quarter, Charles River is raising its forecast for the year. The company said it now expects to achieve 2021 revenue growth of 19%-21%, up from the previous expectation of 16%-18% growth. Nongenerally accepted accounting principles (GAAP) earnings per share is also now expected to range between $9.75-$10, up from the prior forecast of $9-$9.25, Charles River said.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.